Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 150.71 USD 0.22% Market Closed
Market Cap: 22B USD
Have any thoughts about
Biogen Inc?
Write Note

Revenue Breakdown

Breakdown by Geography
Biogen Inc

Not Available

Breakdown by Segments
Biogen Inc

Total Revenue: 9.7B USD
100%
Reportable Segment: 9.7B USD
100%
Product Revenue, Net: 7.2B USD
74.6%
Subtotal: Multiple Sclerosis: 4.3B USD
45%
Subtotal: Rare Disease: 2B USD
20.5%
Revenue From Anti-Cd20 Therapeutic Programs: 1.7B USD
18.1%
Total Fumarate: 1.6B USD
16.5%
Spinraza: 1.6B USD
16.3%
Royalty Revenue On Sales Of Ocrevus: 1.3B USD
13.8%
Total Interferon: 968m USD
10%
Subtotal: Biosimilars: 793.1m USD
8.2%
Contract Manufacturing, Royalty And Other Rev...: 652.6m USD
6.7%
Vumerity: 628m USD
6.5%
Contract Manufacturing Revenue: 592.1m USD
6.1%
Other: 82.5m USD
0.9%
Royalty And Other Revenue: 60.5m USD
0.6%
Alzheimer's Collaboration Revenue: 59.9m USD
0.6%
Qalsody: 32.4m USD
0.3%
Show More
Show Less